VOLTA, Mattia
 Distribuzione geografica
Continente #
NA - Nord America 720
EU - Europa 333
AS - Asia 141
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.198
Nazione #
US - Stati Uniti d'America 718
PL - Polonia 137
CN - Cina 70
DE - Germania 61
FI - Finlandia 43
UA - Ucraina 43
SG - Singapore 40
TR - Turchia 25
IT - Italia 20
GB - Regno Unito 17
BE - Belgio 6
SE - Svezia 5
BR - Brasile 3
ID - Indonesia 3
CA - Canada 2
VN - Vietnam 2
EU - Europa 1
LT - Lituania 1
TW - Taiwan 1
Totale 1.198
Città #
Warsaw 136
Woodbridge 99
Fairfield 88
Ann Arbor 49
Seattle 49
Jacksonville 48
Chandler 46
Houston 46
Ashburn 45
Wilmington 39
Munich 38
Santa Clara 38
Singapore 36
Helsinki 35
Cambridge 31
Beijing 26
Izmir 15
Princeton 12
Shanghai 12
San Diego 10
Boardman 8
Brussels 6
Falls Church 6
Ferrara 6
Nanjing 6
Cagliari 4
Milan 4
Bremen 3
Changsha 3
Hebei 3
Jakarta 3
Jiaxing 3
Redwood City 3
Shenyang 3
Tappahannock 3
Auburn Hills 2
Dearborn 2
Dong Ket 2
Frankfurt am Main 2
Indiana 2
Kunming 2
London 2
Los Angeles 2
Mountain View 2
Nanchang 2
New York 2
Toronto 2
Belém 1
Falkenstein 1
Haikou 1
Hangzhou 1
Jinan 1
Kilburn 1
King Of Prussia 1
North Wales 1
Norwalk 1
Opole 1
Orange 1
Philadelphia 1
Piscataway 1
Rancho Santa Margarita 1
San Jose 1
San Mateo 1
Taipei 1
Taizhou 1
Tianjin 1
Verona 1
Walnut 1
Washington 1
Zhengzhou 1
Totale 1.009
Nome #
Leucine-rich repeat kinase 2, synaptic morphology and motor behavior 201
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 195
Dopamine-nociceptin/orphanin FQ interactions in the substantia nigra reticulata of hemiparkinsonian rats: Involvement of D2/D3 receptors and impact on nigro-thalamic neurons and motor activity 125
Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine release 120
null 108
Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study 108
null 94
null 84
Stimulation of Delta Opioid Receptor and Blockade of Nociceptin/Orphanin FQ Receptor Synergistically Attenuate Parkinsonism 84
Pharmacological profile and antiparkinsonian properties of the novel nociceptin/orphanin FQ receptor antagonist 1-[1-Cyclooctylmethyl-5-(1-hydroxy-1-methyl-ethyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-3-ethyl-1,3-dihydro-benzoimidazol-2-one (GF-4). 33
Further evidence for an involvement of nociceptin/orphanin FQ in the pathophysiology of Parkinson's disease: a behavioral and neurochemical study in reserpinized mice. 29
Stimulation of delta opioid receptors located in substantia nigra reticulata but not globus pallidus or striatum restores motor activity in 6-hydroxydopamine lesioned rats. New insights into the role of delta receptors in parkinsonism. 27
Totale 1.208
Categoria #
all - tutte 4.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.652


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020138 0 0 0 0 0 0 26 27 22 35 18 10
2020/2021170 16 19 6 22 7 14 18 20 6 18 15 9
2021/2022121 3 20 16 1 9 5 7 7 4 8 12 29
2022/2023109 10 7 8 12 16 15 4 12 15 0 6 4
2023/202451 2 10 2 0 8 6 7 8 1 0 0 7
2024/2025169 5 11 21 3 30 60 39 0 0 0 0 0
Totale 1.208